Development of hepatocellular carcinoma organoid model recapitulating HIF-1A metabolic signature

Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. 2018;68(6):394–424.

PubMed  Google Scholar 

Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, Allen C, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015. JAMA Oncol. 2017;3(12):1683–91.

Article  PubMed  PubMed Central  Google Scholar 

Jemal A, Ward EM, Johnson CJ, Cronin KA, Ma J, Ryerson AB, et al. Annual report to the nation on the status of cancer, 1975–2014, featuring survival. JNCI J Natl Cancer Inst. 2017;109(9):djx030.

Article  PubMed  Google Scholar 

El–Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132(7):2557–76.

Article  PubMed  Google Scholar 

Thomlinson RH, Gray LH. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br J Cancer. 1955;9(4):539.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Höckel M, Schlenger K, Knoop C, Vaupel P. Oxygenation of carcinomas of the uterine cervix: evaluation by computerized O2 tension measurements. Can Res. 1991;51(22):6098–102.

Google Scholar 

Vaupel P, Höckel M, Mayer A. Detection and characterization of tumor hypoxia using pO2 histography. Antioxid Redox Signal. 2007;9(8):1221–36.

Article  CAS  PubMed  Google Scholar 

Schwab LP, Peacock DL, Majumdar D, Ingels JF, Jensen LC, Smith KD, et al. Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer. Breast Cancer Res. 2012;14:1–25.

Article  Google Scholar 

Qiu G-Z, Jin M-Z, Dai J-X, Sun W, Feng J-H, Jin W-L. Reprogramming of the tumor in the hypoxic niche: the emerging concept and associated therapeutic strategies. Trends Pharmacol Sci. 2017;38(8):669–86.

Article  CAS  PubMed  Google Scholar 

Tang M, Bolderson E, O’Byrne KJ, Richard DJ. Tumor hypoxia drives genomic instability. Front Cell Dev Biol. 2021;9:626229.

Article  PubMed  PubMed Central  Google Scholar 

Abou Khouzam R, Brodaczewska K, Filipiak A, Zeinelabdin NA, Buart S, Szczylik C, et al. Tumor hypoxia regulates immune escape/invasion: influence on angiogenesis and potential impact of hypoxic biomarkers on cancer therapies. Front Immunol. 2021;11:613114.

Article  PubMed  PubMed Central  Google Scholar 

Soleymani Abyaneh H, Gupta N, Alshareef A, Gopal K, Lavasanifar A, Lai R. Hypoxia induces the acquisition of cancer stem-like phenotype via upregulation and activation of signal transducer and activator of transcription-3 (STAT3) in MDA-MB-231, a triple negative breast cancer cell line. Cancer Microenviron. 2018;11(2):141–52.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rankin EB, Nam J-M, Giaccia AJ. Hypoxia: signaling the metastatic cascade. Trends Cancer. 2016;2(6):295–304.

Article  PubMed  PubMed Central  Google Scholar 

Semenza GL. Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148(3):399–408.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Semenza GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene. 2010;29(5):625–34.

Article  CAS  PubMed  Google Scholar 

Harris AL. Hypoxia—a key regulatory factor in tumour growth. Nat Rev Cancer. 2002;2(1):38–47.

Article  CAS  PubMed  Google Scholar 

Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer. 2003;3(10):721–32.

Article  CAS  PubMed  Google Scholar 

Wada H, Nagano H, Yamamoto H, Yang Y, Kondo M, Ota H, et al. Expression pattern of angiogenic factors and prognosis after hepatic resection in hepatocellular carcinoma: importance of angiopoietin-2 and hypoxia-induced factor-1a. Liver Int. 2006;26(4):414–23.

Article  CAS  PubMed  Google Scholar 

Xia L, Mo P, Huang W, Zhang L, Wang Y, Zhu H, et al. The TNF-α/ROS/HIF-1-induced upregulation of FoxMI expression promotes HCC proliferation and resistance to apoptosis. Carcinogenesis. 2012;33(11):2250–9.

Article  CAS  PubMed  Google Scholar 

Zheng S-S, Chen X-H, Yin X, Zhang B-H. Prognostic significance of HIF-1α expression in hepatocellular carcinoma: a meta-analysis. PLoS ONE. 2013;8(6):e65753.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bangoura G, Liu Z-S, Qian Q, Jiang C-Q, Yang G-F, Jing S. Prognostic significance of HIF-2α/EPAS1 expression in hepatocellular carcinoma. World J Gastroenterol: WJG. 2007;13(23):3176.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yao Q, Lv Y, Pan T, Liu Y, Ma J, Xu G. Prognostic significance and clinicopathological features of hypoxic inducible factor-2alpha expression in hepatocellular carcinoma. Saudi Med J. 2015;36(2):170.

Article  PubMed  PubMed Central  Google Scholar 

Liu P, Fang X, Song Y, Jiang JX, He QJ, Liu XJ. Expression of hypoxia-inducible factor 3α in hepatocellular carcinoma and its association with other hypoxia-inducible factors. Exp Ther Med. 2016;11(6):2470–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Warburg O, Wind F, Negelein E. The metabolism of tumors in the body. J Gen Physiol. 1927;8(6):519.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Denko NC. Hypoxia, HIF1 and glucose metabolism in the solid tumour. Nat Rev Cancer. 2008;8(9):705–13.

Article  CAS  PubMed  Google Scholar 

Cairns RA, Harris IS, Mak TW. Regulation of cancer cell metabolism. Nat Rev Cancer. 2011;11(2):85–95.

Article  CAS  PubMed  Google Scholar 

Semenza GL. HIF-1: upstream and downstream of cancer metabolism. Curr Opin Genet Dev. 2010;20(1):51–6.

Article  CAS  PubMed  Google Scholar 

Marin-Hernandez A, Gallardo-Perez JC, Ralph SJ, Rodriguez-Enriquez S, Moreno-Sanchez R. HIF-1α modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms. Mini Rev Med Chem. 2009;9(9):1084–101.

Article  CAS  PubMed  Google Scholar 

Kim J-w, Tchernyshyov I, Semenza GL, Dang CV. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell Metab. 2006;3(3):177–85.

Article  PubMed  Google Scholar 

Bai Y, Qi W, Liu L, Zhang J, Pang L, Gan T, et al. Identification of seven-gene hypoxia signature for predicting overall survival of hepatocellular carcinoma. Front Genet. 2021;12:637418.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang Y, Zhang H, Chen L, Zhang T, Xu N, Huang Z. Identification of hypoxia-related prognostic signature and competing endogenous RNA regulatory axes in hepatocellular carcinoma. Int J Mol Sci. 2022;23(21):13590.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif